Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
PBYI Stock Forecast, Price & News (Puma Biotechnology)
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
Puma Biotech News, Puma Biotech Quote, PBYI Quote - StreetInsider.com
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Puma Biotechnology - Crunchbase Company Profile & Funding
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Why Puma Biotech Could Get Acquired Between July to September of This Year | BioSpace
Articles with Puma Biotechnology
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | citybiz
Puma Biotechnology falls more than 20%
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Why Puma Biotechnology Is Soaring Today | The Motley Fool
